Hookipa Pharma Inc Asset Turnover Ratio (HOOK), as of first quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Hookipa Pharma inc   (NASDAQ: HOOK)
 

Hookipa Pharma Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Hookipa Pharma Inc 's asset turnover ratio, the ratio that measures the ability of Hookipa Pharma Inc 's assets to generate revenue, sequentially decreased to 0.1 in the first quarter (Mar 31 2025), which does not come as a surprise, as the Hookipa Pharma Inc continue to experience difficult business climate.

Within sector 18 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2025, to 415, from total ranking in the fourth quarter 2024 at 2293.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HOOK Asset Turnover Ratio (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Asset Change -56.92 % -47.38 % -33.59 % -36.1 % -12.26 %
Y / Y Revenue Change -94.52 % -81.72 % -31.51 % -51.85 % 1052.36 %
Asset Turnover Ratio (TTM) 0.1 0.39 0.38 0.36 0.33
HOOK's Total Ranking # 415 # 2293 # 537 # 2397 # 1691
Seq. Asset Change -25.87 % -23.58 % -10.25 % -15.27 % -9.45 %
Seq. Revenue Change 48.01 % -71.21 % 264.57 % -96.48 % 394.11 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 19
Healthcare Sector # 43
Overall Market # 415

Asset Turnover Ratio Statistics
High Average Low
41.46 10.91 3.62
(Dec 31 2023)   (Dec 31 2021)




HOOK Company Profile • Back to HOOK Efficiency Comparisons • Compare HOOK Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2025 Assets at quarter ending Mar 31 2025
Quidelortho Corp  0.42 $ 2,764.700  Millions$ 6,593.875  Millions
Enovis Corp  0.42 $ 2,148.546  Millions$ 5,146.495  Millions
Agenus Inc  0.42 $ 99.524  Millions$ 239.342  Millions
United Therapeutics Corporation  0.41 $ 2,994.100  Millions$ 7,238.550  Millions
Teva Pharmaceutical Industries Limited  0.41 $ 16,617.000  Millions$ 40,209.250  Millions
Teleflex Incorporated  0.41 $ 3,009.984  Millions$ 7,297.284  Millions
Abbvie Inc   0.41 $ 57,367.000  Millions$ 139,171.250  Millions
Surgery Partners Inc   0.41 $ 3,172.900  Millions$ 7,715.550  Millions
Cytek Biosciences Inc   0.40 $ 197.250  Millions$ 489.262  Millions
Arcturus Therapeutics Holdings Inc   0.40 $ 143.680  Millions$ 358.779  Millions
Integra Lifesciences Holdings Corp  0.40 $ 1,624.308  Millions$ 4,057.618  Millions
Ultragenyx Pharmaceutical Inc   0.40 $ 590.689  Millions$ 1,493.046  Millions
Coherus Oncology inc   0.40 $ 197.496  Millions$ 499.864  Millions
Keros Therapeutics Inc   0.39 $ 239.195  Millions$ 608.685  Millions
Outset Medical Inc   0.39 $ 115.415  Millions$ 296.108  Millions
Fortress Biotech Inc   0.39 $ 57.784  Millions$ 148.766  Millions
Celularity Inc   0.39 $ 50.965  Millions$ 131.473  Millions
Zai Lab Limited  0.39 $ 418.326  Millions$ 1,082.949  Millions
Regeneron Pharmaceuticals Inc   0.38 $ 14,085.700  Millions$ 37,208.325  Millions
Gossamer Bio Inc   0.38 $ 124.590  Millions$ 330.052  Millions
Spero Therapeutics Inc   0.38 $ 44.584  Millions$ 118.324  Millions
Enzo Biochem Inc  0.38 $ 27.475  Millions$ 73.020  Millions
Arvinas Inc   0.38 $ 426.900  Millions$ 1,134.800  Millions
Amgen Inc   0.38 $ 34,126.000  Millions$ 90,749.000  Millions
Becton Dickinson And Company  0.38 $ 20,867.000  Millions$ 55,500.000  Millions
Medtronic Plc  0.37 $ 33,537.000  Millions$ 90,361.000  Millions
Marker Therapeutics inc   0.37 $ 5.696  Millions$ 15.400  Millions
Bausch Health Companies Inc   0.37 $ 9,731.000  Millions$ 26,494.750  Millions
Cardiff Lexington Corporation  0.36 $ 8.864  Millions$ 24.368  Millions
Vsee Health Inc   0.36 $ 13.038  Millions$ 35.851  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.